RPL37A and Miyoshi myopathy: Similar to the results of MM cases, SOX7 transcript levels were significantly lower in high-risk SMM cases compared with control samples regardless of whether RPL37A (Figure 8C) or EMC7 (Figure 8D) was used for normalization of the SOX7 gene expression across the samples.